Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FTY 720 Cause Basal cell carcinoma? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Basal cell carcinoma have been filed in association with FTY 720. This represents 7.5% of all adverse event reports for FTY 720.

8
Reports of Basal cell carcinoma with FTY 720
7.5%
of all FTY 720 reports
0
Deaths
1
Hospitalizations

How Dangerous Is Basal cell carcinoma From FTY 720?

Of the 8 reports, 1 (12.5%) required hospitalization.

Is Basal cell carcinoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FTY 720. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does FTY 720 Cause?

Lymphocyte count decreased (10) Central nervous system lesion (7) Gamma-glutamyltransferase increased (7) Multiple sclerosis relapse (7) Pyrexia (6) Alanine aminotransferase increased (5) Aspartate aminotransferase increased (5) Hepatic enzyme increased (5)

What Other Drugs Cause Basal cell carcinoma?

ADALIMUMAB (1,547) INFLIXIMAB (1,340) METHOTREXATE (1,268) RITUXIMAB (1,085) ETANERCEPT (998) ABATACEPT (852) TOCILIZUMAB (761) LENALIDOMIDE (685) HYDROXYCHLOROQUINE (662) LEFLUNOMIDE (657)

Which FTY 720 Alternatives Have Lower Basal cell carcinoma Risk?

FTY 720 vs GABAPENTIN FTY 720 vs GABAPENTIN ENACARBIL FTY 720 vs GADAVIST FTY 720 vs GADOBENATE DIMEGLUMINE FTY 720 vs GADOBUTROL

Related Pages

FTY 720 Full Profile All Basal cell carcinoma Reports All Drugs Causing Basal cell carcinoma FTY 720 Demographics